Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease

Surya P. Bhatt; Gonzalo Vegas-Sánchez-Ferrero; Farbod N. Rahaghi; Erick S. MacLean; German Gonzalez-Serrano; Carolyn E. Come; Gregory L. Kinney; John E. Hokanson; Matthew J. Budoff; Michael J. Cuttica; J. Michael Wells; Raúl San José Estépar; George R. Washko

doi:10.1164/rccm.201702-0399LE

Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease

Surya P. Bhatt, Gonzalo Vegas-Sánchez-Ferrero, Farbod N. Rahaghi, Erick S. MacLean, German Gonzalez-Serrano, Carolyn E. Come, Gregory L. Kinney, John E. Hokanson, Matthew J. Budoff, Michael J. Cuttica, J. Michael Wells, Raúl San José Estépar, George R. Washko

Medicine, Pulmonary Division

Research output: Contribution to journal › Letter › peer-review

18 Scopus citations

Original language	English (US)
Pages (from-to)	1484-1488
Number of pages	5
Journal	American journal of respiratory and critical care medicine
Volume	196
Issue number	11
DOIs	https://doi.org/10.1164/rccm.201702-0399LE
State	Published - Dec 1 2017

Funding

Supported by awards R01 HL089897, R01 HL089856, R01HL116473, and R01HL116931 from the NHLBI. S.P.B. is supported by National Institutes of Health K23 grant K23HL133438. The COPDGene project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, Sunovion, and GlaxoSmithKline. Acknowledgment: The authors thank Alejandro A. Diaz, M.D., M.P.H. (Brigham and Women’s Hospital), Ravi Kalhan, M.D. (Northwestern University), and Mark T. Dransfield, M.D. (University of Alabama at Birmingham) for their valuable input. Supported by awards R01 HL089897, R01 HL089856, R01HL116473, and R01HL116931 from the NHLBI. S.P.B. is supported by National Institutes of Health K23 grant K23HL133438. The COPDGene project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, Sunovion, and GlaxoSmithKline.

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Critical Care and Intensive Care Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1164/rccm.201702-0399LE

Cite this

Bhatt, S. P., Vegas-Sánchez-Ferrero, G., Rahaghi, F. N., MacLean, E. S., Gonzalez-Serrano, G., Come, C. E., Kinney, G. L., Hokanson, J. E., Budoff, M. J., Cuttica, M. J., Wells, J. M., Estépar, R. S. J., & Washko, G. R. (2017). Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 196(11), 1484-1488. https://doi.org/10.1164/rccm.201702-0399LE

@article{3acd4e9a9d7847fc8211e0246feee4ec,

title = "Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease",

author = "Bhatt, {Surya P.} and Gonzalo Vegas-S{\'a}nchez-Ferrero and Rahaghi, {Farbod N.} and MacLean, {Erick S.} and German Gonzalez-Serrano and Come, {Carolyn E.} and Kinney, {Gregory L.} and Hokanson, {John E.} and Budoff, {Matthew J.} and Cuttica, {Michael J.} and Wells, {J. Michael} and Est{\'e}par, {Ra{\'u}l San Jos{\'e}} and Washko, {George R.}",

note = "Funding Information: Supported by awards R01 HL089897, R01 HL089856, R01HL116473, and R01HL116931 from the NHLBI. S.P.B. is supported by National Institutes of Health K23 grant K23HL133438. The COPDGene project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, Sunovion, and GlaxoSmithKline. Acknowledgment: The authors thank Alejandro A. Diaz, M.D., M.P.H. (Brigham and Women{\textquoteright}s Hospital), Ravi Kalhan, M.D. (Northwestern University), and Mark T. Dransfield, M.D. (University of Alabama at Birmingham) for their valuable input. Funding Information: Supported by awards R01 HL089897, R01 HL089856, R01HL116473, and R01HL116931 from the NHLBI. S.P.B. is supported by National Institutes of Health K23 grant K23HL133438. The COPDGene project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, Sunovion, and GlaxoSmithKline.",

year = "2017",

month = dec,

day = "1",

doi = "10.1164/rccm.201702-0399LE",

language = "English (US)",

volume = "196",

pages = "1484--1488",

journal = "American journal of respiratory and critical care medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

number = "11",

}

Bhatt, SP, Vegas-Sánchez-Ferrero, G, Rahaghi, FN, MacLean, ES, Gonzalez-Serrano, G, Come, CE, Kinney, GL, Hokanson, JE, Budoff, MJ, Cuttica, MJ, Wells, JM, Estépar, RSJ & Washko, GR 2017, 'Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease', American journal of respiratory and critical care medicine, vol. 196, no. 11, pp. 1484-1488. https://doi.org/10.1164/rccm.201702-0399LE

Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease. / Bhatt, Surya P.; Vegas-Sánchez-Ferrero, Gonzalo; Rahaghi, Farbod N. et al.
In: American journal of respiratory and critical care medicine, Vol. 196, No. 11, 01.12.2017, p. 1484-1488.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease

AU - Bhatt, Surya P.

AU - Vegas-Sánchez-Ferrero, Gonzalo

AU - Rahaghi, Farbod N.

AU - MacLean, Erick S.

AU - Gonzalez-Serrano, German

AU - Come, Carolyn E.

AU - Kinney, Gregory L.

AU - Hokanson, John E.

AU - Budoff, Matthew J.

AU - Cuttica, Michael J.

AU - Wells, J. Michael

AU - Estépar, Raúl San José

AU - Washko, George R.

N1 - Funding Information: Supported by awards R01 HL089897, R01 HL089856, R01HL116473, and R01HL116931 from the NHLBI. S.P.B. is supported by National Institutes of Health K23 grant K23HL133438. The COPDGene project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, Sunovion, and GlaxoSmithKline. Acknowledgment: The authors thank Alejandro A. Diaz, M.D., M.P.H. (Brigham and Women’s Hospital), Ravi Kalhan, M.D. (Northwestern University), and Mark T. Dransfield, M.D. (University of Alabama at Birmingham) for their valuable input. Funding Information: Supported by awards R01 HL089897, R01 HL089856, R01HL116473, and R01HL116931 from the NHLBI. S.P.B. is supported by National Institutes of Health K23 grant K23HL133438. The COPDGene project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Siemens, Sunovion, and GlaxoSmithKline.

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85038118069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038118069&partnerID=8YFLogxK

U2 - 10.1164/rccm.201702-0399LE

DO - 10.1164/rccm.201702-0399LE

M3 - Letter

C2 - 28441027

AN - SCOPUS:85038118069

SN - 1073-449X

VL - 196

SP - 1484

EP - 1488

JO - American journal of respiratory and critical care medicine

JF - American journal of respiratory and critical care medicine

IS - 11

ER -

Cardiac morphometry on computed tomography and exacerbation reduction with β-blocker therapy in chronic obstructive pulmonary disease

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this